Ulrika NorinCEO at Serendo Therapeutics ABPresenter
Profile
Ulrika Norin is CEO and founder of Serendo Therapeutics AB. She holds a Ph.D. in immunology from Karolinska Institutet and has over a decade of experience in autoimmune disease research, translational drug discovery, and biotech leadership. She has led the development of early-stage therapeutics through initial regulatory engagement and raised over €10 million in public and private funding across multiple ventures.
Agenda Sessions
Startup Spotlight pitch competition
, 15:00View Session
